血小板PI3Kβ调节乳腺癌的转移
bioRxiv : the preprint server for biology
|September 24, 2024
概括
血小板IA类的酸酸3-激酶β (PI3Kβ) 驱动乳腺癌的转移. 抑制血小板中的PI3Kβ可能提供一种治疗癌症扩散的新策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 血小板通过各种机制促进瘤转移,包括促进癌细胞入侵和扩散.
- 血小板激活对于血栓形成至关重要,它依赖于IA类的酸酸盐3-酶β (PI3Kβ).
研究的目的:
- 研究血小板PI3Kβ在乳腺癌转移中的作用.
- 探索PI3Kβ作为抑制癌症转移的潜在治疗标.
主要方法:
- 利用PI3Kβ突变小鼠在体外和体内评估血小板功能.
- 在共同培养的人类乳腺上皮细胞和血小板上进行RNAseq和蛋白质组分析.
- 研究PI3Kβ对瘤细胞信号通路 (YAP和Smad2) 的影响.
- 在小鼠模型中评估了自发和实验转移.
主要成果:
- 血小板PI3Kβ对于血小板刺激的瘤细胞入侵和转移至关重要.
- 血小板中的PI3Kβ缺乏减少了体外瘤细胞结合和血小板激活.
- 血小板PI3Kβ调节表皮质-介质细胞转变 (EMT) 和转移相关基因的表达,包括PAI-1和IL-8.
- PI3Kβ突变血小板损害了瘤细胞中的YAP和Smad2信号传递.
- 具有突变PI3Kβ的小鼠表现出减少的自发转移,他们的血小板在促进实验转移方面效率较低.
结论:
- 血小板PI3Kβ在促进乳腺癌转移方面发挥着关键作用.
- 用选择性抑制剂向血小板PI3Kβ是一种有希望的治疗策略,用于治疗癌症转移.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


